Pancreatic Cancer Research

ResearcherShanghai Jiao Tong UniversityNo recent work listed

Li Huang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-8448-3481; OpenAlex author ID A5016584286. Sources: OpenAlex.

Their work

Papers
3 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
9
Papers, trials and grants by year

2021: 1 paper · 2022: none · 2023: 2 papers

Papers 3

  1. Retraction Note: Transcriptional repression of SOCS3 mediated by IL-6/STAT3 signaling via DNMT1 promotes pancreatic cancer growth and metastasis. Co-author DOI 10.1186/s13046-023-02595-3↗
  2. Erratum: Shikonin induces apoptosis and necroptosis in pancreatic cancer via regulating the expression of RIP1/RIP3 and synergizes the activity of gemcitabine. Co-author PMID 38074805↗
  3. Dyslipidemia in Chinese Pancreatic Cancer Patients: A Two-Center Retrospective Study. First author DOI 10.7150/jca.60340↗

Closest collaborators

The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Congying Chen · 2 shared papers, 2023 · strength 0.36
  2. Guoyong Hu · 2 shared papers, 2023 · strength 0.36
  3. Lijuan Yang · 2 shared papers, 2023 · strength 0.36
  4. Rong Wan · 1 shared paper, 2023 · strength 0.19
  5. Yue Zeng · 1 shared paper, 2023 · strength 0.17
  6. Xingpeng Wang · 1 shared paper, 2023 · strength 0.17
  7. Feiyang Wang · 1 shared paper, 2021 · strength 0.16
  8. Junming Xu · 1 shared paper, 2021 · strength 0.16
  9. Heshui Wu · 1 shared paper, 2021 · strength 0.16

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.